Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid.

The precursor of the non-A beta component of Alzheimer's disease amyloid (NACP) is a presynaptic protein whose function has been suspected to be tightly involved in neuronal biogenesis including synaptic regulations. NACP was suggested to seed the neuritic plaque formation in the presence of A beta during the development of Alzheimer's disease (AD). Recombinant NACP purified through heat treatment, DEAE-Sephacel anion-exchange, Sephacryl S-200 size-exclusion, and S-Sepharose cation-exchange chromatography steps appeared as a single band on SDS-PAGE with Mr of 19 kDa. Its N-terminal amino acid sequence clearly confirmed that the protein was NACP. Interestingly, however, the protein was split into a doublet on a nondenaturing (ND)-PAGE with equal intensities. The doublet was located slightly above a 45-kDa marker protein on a 12.5% ND-PAGE. In addition, the size of NACP was more carefully estimated as 53 kDa with high-performance gel-permeation chromatography using a TSK G3000sw size-exclusion column. Recently, Lansbury and his colleagues (Biochemistry 35, 13709-13715) have reported that NACP exists as an elongated "natively unfolded" structure which would make the protein more actively involved in protein-protein interactions and Kim (Mol. Cells 7, 78-83) has also shown that the natively unfolded protein is extremely sensitive to proteases. Here, we report that the structure of NACP could be altered by certain environmental factors. Aluminum, a suspected risk factor for AD, converged the doublet of NACP into a singlet with slightly lower mobility on ND-PAGE. Spectroscopic analysis employing uv absorption, intrinsic fluorescence, and circular dichroism indicated that NACP experienced the structural alterations in the presence of aluminum such as the secondary structure transition to generate about 33% alpha-helix. This altered structure of NACP became resistant to proteases such as trypsin, alpha-chymotrypsin, and calpain. Therefore, it is suggested that aluminum, which influences two pathologically critical processes in AD such as the protein turnover and the protein aggregation via the structural modifications, could participate in the disease.

[1]  G. Johnson,et al.  Phosphorylation of τ In Situ: Inhibition of Calcium‐Dependent Proteolysis , 1995, Journal of neurochemistry.

[2]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Kim.  Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. , 1997, Molecules and cells.

[4]  D. Selkoe.  Amyloid β protein precursor and the pathogenesis of Alzheimer's disease , 1989, Cell.

[5]  E. Krebs,et al.  Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. , 1991, The Journal of biological chemistry.

[6]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[7]  L. Yang,et al.  Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. , 1995, European journal of biochemistry.

[8]  E. Perry,et al.  ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE , 1986, The Lancet.

[9]  R. Nixon,et al.  Calcium‐Activated Neutral Proteinase of Human Brain: Subunit Structure and Enzymatic Properties of Multiple Molecular Forms , 1986, Journal of neurochemistry.

[10]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[11]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[12]  R. Jope,et al.  Proteolysis of tau by calpain. , 1989, Biochemical and biophysical research communications.

[13]  P. Lansbury,et al.  The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.

[14]  D. Selkoe,et al.  Biochemistry of altered brain proteins in Alzheimer's disease. , 1989, Annual review of neuroscience.

[15]  S. Nakajo,et al.  A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. , 1993, European journal of biochemistry.

[16]  D. Price,et al.  Amyloidosis in aging and Alzheimer's disease. , 1992, The American journal of pathology.

[17]  T B Shea,et al.  Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.

[18]  D. Crapper,et al.  Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration , 1973, Science.

[19]  K. Muramoto,et al.  Aluminum Promotes the Aggregation of Alzheimer′s Amyloid β-Protein in Vitro , 1994 .

[20]  G. Demartino,et al.  Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.

[21]  D. Perl,et al.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. , 1980, Science.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[23]  J. Wood,et al.  Peripheral Nervous System-specific Genes Identified by Subtractive cDNA Cloning (*) , 1995, The Journal of Biological Chemistry.

[24]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[25]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[26]  R. Kalaria,et al.  Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease , 1995, Nature Medicine.

[27]  R. Martin.  The chemistry of aluminum as related to biology and medicine. , 1986, Clinical chemistry.

[28]  R. Scheller,et al.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[30]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[31]  P. Gambetti,et al.  Aluminum and Alzheimer's disease: perspectives for a cytoskeletal mechanism. , 1987, Critical reviews in clinical laboratory sciences.

[32]  K. Beyreuther,et al.  Molecular biology of Alzheimer's disease. , 1989, Annual review of biochemistry.

[33]  D. Perl.  Relationship of aluminum to Alzheimer's disease. , 1985, Environmental health perspectives.

[34]  P. Zatta,et al.  The Inhibition of Trypsin and α-Chymotrypsin Proteolytic Activity by Aluminum(III) , 1993 .

[35]  D. Selkoe,et al.  Biochemical and immunological characterization of neurofilaments in experimental neurofibrillary degeneration induced by aluminum , 1979, Brain Research.

[36]  C. Cotman,et al.  Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Clauberg,et al.  Regulation of serine protease activity by aluminum: implications for Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Goate,et al.  Role of the β-amyloid precursor protein in Alzheimer's disease , 1994 .

[39]  D. Clair,et al.  Synuclein proteins and Alzheimer's disease , 1994, Trends in Neurosciences.

[40]  G. Fasman,et al.  The solubilization of model Alzheimer tangles: reversing the beta-sheet conformation induced by aluminum with silicates. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Fasman,et al.  Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[43]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[44]  T. Shea,et al.  Aluminum inhibits neurofilament protein degradation by multiple cytoskeleton‐associated proteases , 1992, FEBS letters.

[45]  E. Masliah,et al.  Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. , 1995, Biochemistry.

[46]  D. Perl,et al.  Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. , 1982, Science.

[47]  M. Yoshimoto,et al.  NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Johnson,et al.  Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. , 1992, The Journal of biological chemistry.

[49]  G. Moore,et al.  Aluminium transport in blood serum. Binding of aluminium by human transferrin in the presence of human albumin and citrate. , 1991, The Biochemical journal.

[50]  G. Johnson.  Differential Phosphorylation of τ by Cyclic AMP‐Dependent Protein Kinase and Ca2+/Calmodulin‐Dependent Protein Kinase II: Metabolic and Functional Consequences , 1992 .

[51]  H. Mori,et al.  Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid. , 1994, Biochemical and biophysical research communications.

[52]  R. Scheller,et al.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane. , 1991, Brain research. Molecular brain research.